Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ADIPOSOME is a preclinical exosome-based therapeutic candidate developed by Exostemtech, specifically designed for adipose tissue remodeling. As an exosome therapy, it leverages extracellular vesicles derived from stem cells to deliver a complex cargo of proteins, lipids, and nucleic acids to target cells. The primary goal of ADIPOSOME is to modulate the microenvironment of adipose tissue, promoting healthy tissue regeneration and structural remodeling. This approach is being explored for potential applications in plastic and reconstructive surgery, as well as the treatment of metabolic conditions associated with adipose dysfunction. By utilizing the natural signaling capabilities of exosomes, ADIPOSOME aims to provide a cell-free alternative to traditional stem cell therapies, potentially offering improved safety and stability profiles.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ADIPOSOME.